Indication

Extra-pancreatic neuroendocrine tumor

An extra-pancreatic neuroendocrine tumor is a heterogeneous neoplasm arising from neuroendocrine cells situated outside the pancreas, most frequently within the gastrointestinal tract (such as the small intestine, appendix, stomach, or rectum) and the bronchopulmonary system. Read more about Extra-pancreatic neuroendocrine tumor

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Extra-pancreatic neuroendocrine tumor therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Extra-pancreatic neuroendocrine tumor preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Extra-pancreatic neuroendocrine tumor.

An extra-pancreatic neuroendocrine tumor is a heterogeneous neoplasm arising from neuroendocrine cells situated outside the pancreas, most frequently within the gastrointestinal tract (such as the small intestine, appendix, stomach, or rectum) and the bronchopulmonary system.

Affecting adults across various demographics, these tumors originate from the diffuse endocrine system and are characterized by neurosecretory granules expressing markers such as synaptophysin and chromogranin A.

Pathophysiologically, they may be nonfunctioning or functioning; functioning subtypes secrete excess bioactive amines and peptides (notably serotonin), which can precipitate paraneoplastic conditions like carcinoid syndrome.

Clinically, these tumors range from slow-growing, well-differentiated lesions to aggressive, poorly differentiated carcinomas that frequently present with mass effect, abdominal discomfort, bowel obstruction, flushing, diarrhea, or metastatic disease, commonly to the liver.

Personalize your experience

Follow Extra-pancreatic neuroendocrine tumor and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it